Recently signed agreements with four contract research organizations (“CROs”) to initiate GMP manufacturing, develop inhalation technology, conduct inhalation safety toxicity […]
Completed Successful Restart of all 20 facilities in May; Refinanced Credit Facility in JuneSecond Quarter Highlights:Produced Net Sales of $120.0 millionResults […]